Showing all 10 results

  • rispond 1

    RISPOND 1 – Risperidone

    For the treatment of schizophrenia and symptoms
    of psychotic disorders.
    – For long-term treatment in order to sustain the
    improvement in the state of the illness in patients
    who have exhibited an initial response.
    – For the treatment of psychotic manifestations of
    moderate to severe dementia, only in Alzheimer’s
    disease (short-term treatment up to 6 weeks in
    a situation of consistent aggression), in patients
    who are not responding to non-pharmacological
    treatment and there is concern that they will harm
    themselves or others.
    – For treatment of mania in bipolar disorder.
    – For the treatment of behavioral disorders such
    as violence, impulsiveness and self aggression in
    children over 5 years of age and in adults who are
    intellectually handicapped.


    RISPOND 1 – Risperidone

    For the treatment of schizophrenia and symptoms of psychotic disorders. – For long-term treatment in order to sustain the improvement in the state of the illness in patients who have exhibited an initial response. – For the treatment of psychotic manifestations of moderate to severe dementia, only in Alzheimer’s disease (short-term treatment up to 6 weeks in a situation of consistent aggression), in patients who are not responding to non-pharmacological treatment and there is concern that they will harm themselves or others. – For treatment of mania in bipolar disorder. – For the treatment of behavioral disorders such as violence, impulsiveness and self aggression in children over 5 years of age and in adults who are intellectually handicapped.

    Read More

  • rispond 2

    RISPOND 2 – Risperidone

    For the treatment of schizophrenia and symptoms
    of psychotic disorders.
    – For long-term treatment in order to sustain the
    improvement in the state of the illness in patients
    who have exhibited an initial response.
    – For the treatment of psychotic manifestations of
    moderate to severe dementia, only in Alzheimer’s
    disease (short-term treatment up to 6 weeks in
    a situation of consistent aggression), in patients
    who are not responding to non-pharmacological
    treatment and there is concern that they will harm
    themselves or others.
    – For treatment of mania in bipolar disorder.
    – For the treatment of behavioral disorders such
    as violence, impulsiveness and self aggression in
    children over 5 years of age and in adults who are
    intellectually handicapped.


    RISPOND 2 – Risperidone

    For the treatment of schizophrenia and symptoms of psychotic disorders. – For long-term treatment in order to sustain the improvement in the state of the illness in patients who have exhibited an initial response. – For the treatment of psychotic manifestations of moderate to severe dementia, only in Alzheimer’s disease (short-term treatment up to 6 weeks in a situation of consistent aggression), in patients who are not responding to non-pharmacological treatment and there is concern that they will harm themselves or others. – For treatment of mania in bipolar disorder. – For the treatment of behavioral disorders such as violence, impulsiveness and self aggression in children over 5 years of age and in adults who are intellectually handicapped.

    Read More

  • rispond 3

    RISPOND 3 – Risperidone

    For the treatment of schizophrenia and symptoms
    of psychotic disorders.
    – For long-term treatment in order to sustain the
    improvement in the state of the illness in patients
    who have exhibited an initial response.
    – For the treatment of psychotic manifestations of
    moderate to severe dementia, only in Alzheimer’s
    disease (short-term treatment up to 6 weeks in
    a situation of consistent aggression), in patients
    who are not responding to non-pharmacological
    treatment and there is concern that they will harm
    themselves or others.
    – For treatment of mania in bipolar disorder.
    – For the treatment of behavioral disorders such
    as violence, impulsiveness and self aggression in
    children over 5 years of age and in adults who are
    intellectually handicapped.


    RISPOND 3 – Risperidone

    For the treatment of schizophrenia and symptoms of psychotic disorders. – For long-term treatment in order to sustain the improvement in the state of the illness in patients who have exhibited an initial response. – For the treatment of psychotic manifestations of moderate to severe dementia, only in Alzheimer’s disease (short-term treatment up to 6 weeks in a situation of consistent aggression), in patients who are not responding to non-pharmacological treatment and there is concern that they will harm themselves or others. – For treatment of mania in bipolar disorder. – For the treatment of behavioral disorders such as violence, impulsiveness and self aggression in children over 5 years of age and in adults who are intellectually handicapped.

    Read More

  • rispond-4-eng

    RISPOND 4 – Risperidone

    For the treatment of schizophrenia and symptoms
    of psychotic disorders.
    – For long-term treatment in order to sustain the
    improvement in the state of the illness in patients
    who have exhibited an initial response.
    – For the treatment of psychotic manifestations of
    moderate to severe dementia, only in Alzheimer’s
    disease (short-term treatment up to 6 weeks in
    a situation of consistent aggression), in patients
    who are not responding to non-pharmacological
    treatment and there is concern that they will harm
    themselves or others.
    – For treatment of mania in bipolar disorder.
    – For the treatment of behavioral disorders such
    as violence, impulsiveness and self aggression in
    children over 5 years of age and in adults who are
    intellectually handicapped.


    RISPOND 4 – Risperidone

    For the treatment of schizophrenia and symptoms of psychotic disorders. – For long-term treatment in order to sustain the improvement in the state of the illness in patients who have exhibited an initial response. – For the treatment of psychotic manifestations of moderate to severe dementia, only in Alzheimer’s disease (short-term treatment up to 6 weeks in a situation of consistent aggression), in patients who are not responding to non-pharmacological treatment and there is concern that they will harm themselves or others. – For treatment of mania in bipolar disorder. – For the treatment of behavioral disorders such as violence, impulsiveness and self aggression in children over 5 years of age and in adults who are intellectually handicapped.

    Read More

  • rispond solution

    RISPOND ORAL SOLUTION

    For the treatment of schizophrenia and symptoms
    of psychotic disorders.
    – For long-term treatment in order to sustain the
    improvement in the state of the illness in patients
    who have exhibited an initial response.
    – For the treatment of psychotic manifestations of
    moderate to severe dementia, only in Alzheimer’s
    disease (short-term treatment up to 6 weeks in
    a situation of consistent aggression), in patients
    who are not responding to non-pharmacological
    treatment and there is concern that they will harm
    themselves or others.
    – For treatment of mania in bipolar disorder.
    – For the treatment of behavioral disorders such
    as violence, impulsiveness and self aggression in
    children over 5 years of age and in adults who are
    intellectually handicapped.


    RISPOND ORAL SOLUTION

    For the treatment of schizophrenia and symptoms of psychotic disorders. – For long-term treatment in order to sustain the improvement in the state of the illness in patients who have exhibited an initial response. – For the treatment of psychotic manifestations of moderate to severe dementia, only in Alzheimer’s disease (short-term treatment up to 6 weeks in a situation of consistent aggression), in patients who are not responding to non-pharmacological treatment and there is concern that they will harm themselves or others. – For treatment of mania in bipolar disorder. – For the treatment of behavioral disorders such as violence, impulsiveness and self aggression in children over 5 years of age and in adults who are intellectually handicapped.

    Read More

  • zappa 10

    ZAPPA 10 – Olanzapine

    An antipsychotic preparation for treatment of schizophrenia
    and symptoms of psychotic disorders. In addition, it is intended
    to treat bipolar affective disorder.


    ZAPPA 10 – Olanzapine

    An antipsychotic preparation for treatment of schizophrenia and symptoms of psychotic disorders. In addition, it is intended to treat bipolar affective disorder.

    Read More

  • zappa 5

    ZAPPA 5 – Olanzapine

    An antipsychotic preparation for treatment of schizophrenia
    and symptoms of psychotic disorders. In addition, it is intended
    to treat bipolar affective disorder.


    ZAPPA 5 – Olanzapine

    An antipsychotic preparation for treatment of schizophrenia and symptoms of psychotic disorders. In addition, it is intended to treat bipolar affective disorder.

    Read More

  • zappa 7.5

    ZAPPA 7.5 – Olanzapine

    An antipsychotic preparation for treatment of schizophrenia
    and symptoms of psychotic disorders. In addition, it is intended
    to treat bipolar affective disorder.


    ZAPPA 7.5 – Olanzapine

    An antipsychotic preparation for treatment of schizophrenia and symptoms of psychotic disorders. In addition, it is intended to treat bipolar affective disorder.

    Read More

  • zappa odt 5

    ZAPPA ODT 5 – Olanzapine

    An antipsychotic preparation for treatment of schizophrenia
    and symptoms of psychotic disorders. In addition, it is intended
    to treat bipolar affective disorder.


    ZAPPA ODT 5 – Olanzapine

    An antipsychotic preparation for treatment of schizophrenia and symptoms of psychotic disorders. In addition, it is intended to treat bipolar affective disorder.

    Read More

  • zappa odt 10

    ZAPPA ODT10 – Olanzapine

    An antipsychotic preparation for treatment of schizophrenia
    and symptoms of psychotic disorders. In addition, it is intended
    to treat bipolar affective disorder.


    ZAPPA ODT10 – Olanzapine

    An antipsychotic preparation for treatment of schizophrenia and symptoms of psychotic disorders. In addition, it is intended to treat bipolar affective disorder.

    Read More